|
1
|
Chiaretti S and Foà R: T-cell acute
lymphoblastic leukemia. Haematologica. 94:160–162. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pui CH, Robison LL and Look AT: Acute
lymphoblastic leukaemia. Lancet. 371:1030–1043. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferrando AA, Neuberg DS, Staunton J, Loh
ML, Huard C, Raimondi SC, Behm FG, Pui CH, Downing JR, Gilliland
DG, Lander ES, Golub TR and Look AT: Gene expression signatures
define novel oncogenic pathways in T cell acute lymphoblastic
leukemia. Cancer Cell. 1:75–87. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pui CH and Evans WE: Treatment of acute
lymphoblastic leukemia. N Engl J Med. 354:166–178. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bhojwani D and Pui CH: Relapsed childhood
acute lymphoblastic leukaemia. Lancet Oncol. 14:e205–e217. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kelley CM, Ikeda T, Koipally J, Avitahl N,
Wu L, Georgopoulos K and Morgan BA: Helios, a novel dimerization
partner of Ikaros expressed in the earliest hematopoietic
progenitors. Curr Biol. 8:508–515. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morgan B, Sun L, Avitahl N, Andrikopoulos
K, Ikeda T, Gonzales E, Wu P, Neben S and Georgopoulos K: Aiolos, a
lymphoid restricted transcription factor that interacts with Ikaros
to regulate lymphocyte differentiation. EMBO J. 16:2004–2013. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Georgopoulos K, Winandy S and Avitahl N:
The role of the Ikaros gene in lymphocyte development and
homeostasis. Ann Rev Immunol. 15:155–176. 1997. View Article : Google Scholar
|
|
9
|
Narvi E, Nera KP, Terho P, Mustonen L,
Granberg J and Lassila O: Aiolos controls gene conversion and cell
death in DT40 B cells. Scand J Immunol. 65:503–513. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rebollo A, Ayllón V, Fleischer A, Martínez
CA and Zaballos A: The association of Aiolos transcription factor
and Bcl-xL is involved in the control of apoptosis. J
Immunol. 167:6366–6373. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Romero F, Martínez-A C, Camonis J and
Rebollo A: Aiolos transcription factor controls cell death in T
cells by regulating Bcl-2 expression and its cellular localization.
EMBO J. 18:3419–3430. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakase K, Ishimaru F, Avitahl N, Dansako
H, Matsuo K, Fujii K, Sezaki N, Nakayama H, Yano T, Fukuda S,
Imajoh K, Takeuchi M, Miyata A, Hara M, Yasukawa M, Takahashi I,
Taguchi H, Matsue K, Nakao S, Niho Y, Takenaka K, Shinagawa K,
Ikeda K, Niiya K and Harada M: Dominant negative isoform of the
Ikaros gene in patients with adult B-cell acute lymphoblastic
leukemia. Cancer Res. 60:4062–4065. 2000.PubMed/NCBI
|
|
13
|
Nückel H, Frey UH, Sellmann L, Collins CH,
Duhrsen U and Siffert W: The IKZF3 (Aiolos) transcription factor is
highly upregulated and inversely correlated with clinical
progression in chronic lymphocytic leukaemia. Br J Haematol.
144:268–270. 2009. View Article : Google Scholar
|
|
14
|
Billot K, Soeur J, Chereau F, Arrouss I,
Merle-Beral H, Huang ME, Mazier D, Baud V and Rebollo A:
Deregulation of Aiolos expression in chronic lymphocytic leukemia
is associated with epigenetic modifications. Blood. 117:1917–1927.
2011. View Article : Google Scholar
|
|
15
|
Antica M, Cicin-Sain L, Kapitanovic S,
Matulic M, Dzebro S and Dominis M: Aberrant Ikaros, Aiolos, and
Helios expression in Hodgkin and non-Hodgkin lymphoma. Blood.
111:3296–3297. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhuang Y, Li D, Fu J, Shi Q, Lu Y and Ju
X: Overexpression of AIOLOS inhibits cell proliferation and
suppresses apoptosis in Nalm-6 cells. Oncol Rep. 31:1183–1190.
2014.PubMed/NCBI
|
|
17
|
Frescas D and Pagano M: Deregulated
proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the
scales of cancer. Nat Rev Cancer. 8:438–449. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hershko DD: Oncogenic properties and
prognostic implications of the ubiquitin ligase Skp2 in cancer.
Cancer. 112:1415–1424. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Z, Fukushima H, Inuzuka H, Wan L, Liu
P, Gao D, Sarkar FH and Wei W: Skp2 is a promising therapeutic
target in breast cancer. Front Oncol. 1:pii: 18702. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kitagawa M, Lee SH and McCormick F: Skp2
suppresses p53-dependent apoptosis by inhibiting p300. Mol Cell.
29:217–231. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin HK, Wang G, Chen Z, Teruya-Feldstein
J, Liu Y, Chan CH, Yang WL, Erdjument-Bromage H, Nakayama KI, Nimer
S, Tempst P and Pandolfi PP: Phosphorylation-dependent regulation
of cytosolic localization and oncogenic function of Skp2 by
Akt/PKB. Nat Cell Biol. 11:420–432. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stella S, Tirrò E, Conte E, Stagno F, Di
Raimondo F, Manzella L and Vigneri P: Suppression of survivin
induced by a BCR-ABL/JAK2/STAT3 pathway sensitizes
imatinib-resistant CML cells to different cytotoxic drugs. Mol
Cancer Ther. 12:1085–1098. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang
QC, Zhang YJ, Lu R, Chen YX and Fang JY: Inhibition of JAK1,
2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces
tumor cell invasion in colorectal cancer cells. Neoplasia.
10:287–297. 2008.PubMed/NCBI
|
|
24
|
Kirkin V, Joos S and Zörnig M: The role of
Bcl-2 family members in tumorigenesis. Biochim Biophys Acta.
1644:229–249. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Martins LM, Mesner PW, Kottke TJ, Basi GS,
Sinha S, Tung JS, Svingen PA, Madden BJ, Takahashi A, McCormick DJ,
Earnshaw WC and Kaufmann SH: Comparison of caspase activation and
subcellular localization in HL-60 and K562 cells undergoing
etoposide-induced apoptosis. Blood. 90:4283–4296. 1997.PubMed/NCBI
|
|
26
|
Montecucco A and Biamonti G: Cellular
response to etoposide treatment. Cancer Lett. 252:9–18. 2007.
View Article : Google Scholar
|
|
27
|
Karin M and Greten FR: NF-κB: linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005. View
Article : Google Scholar : PubMed/NCBI
|
